This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
AUA announces amendments to castration resistant prostate cancer clinical practice guideline
May 18, 2014
Dogs detect prostate cancer in men at a remarkably high rate of accuracy
May 18, 2014
European Urology published groundbreaking results from three studies demonstrating Genomic Health's Oncotype DX® test predicts prostate cancer aggressiveness at diagnosis
May 17, 2014
Benefits, outcomes and limitations of active surveillance for prostate cancer
May 17, 2014
Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer - Abstract
May 16, 2014
The epidemiology and clinical implications of genetic variation in prostate cancer - Abstract
May 16, 2014
What do the screening trials really tell us and where do we go from here? - Abstract
May 16, 2014
Evolution and immediate future of US screening guidelines - Abstract
May 16, 2014
Optimization of prostate biopsy: Review of technique and complications - Abstract
May 16, 2014
Incidental prostate cancer at the time of cystectomy: The incidence and clinicopathological features in Chinese patients - Abstract
May 16, 2014
Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged less than 70 and >= 70 years
May 16, 2014
Dual optimization based prostate zonal segmentation in 3D MR images - Abstract
May 15, 2014
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: Evaluation of shortening of treatment period to 3 weeks - Abstract
May 15, 2014
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men - Abstract
May 15, 2014
Clinical presentation of prostate cancer in Black South Africans - Abstract
May 15, 2014
A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy - Abstract
May 15, 2014
Transurethral resection of the prostate after radiotherapy for prostate cancer: Impact on quality of life - Abstract
May 15, 2014
Cancer stem cells in prostate cancer chemoresistance - Abstract
May 15, 2014
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer - Abstract
May 15, 2014
Dendreon announces presentation of PROVENGE® (sipuleucel-T) and DN24-02 immuno-oncology data at the 2014 ASCO Annual Meeting
May 15, 2014
Page 1010 of 1418
Start
Prev
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free